The Role of the Calcium-Sensing Receptor in the Pathophysiology of Secondary Hyperparathyroidism

The calcium-sensing receptor (CaR), a seven-transmembrane domain receptor belonging to the G protein-coupled receptor family, is responsible for calcium-mediated signalling initiated at the surface of parathyroid cells that controls the synthesis and secretion of parathyroid hormone (PTH). Expression of the CaR is downregulated in animal models of uraemia and in patients with secondary hyperparathyroidism (SHPT). Cinacalcet is a type II calcimimetic agent that acts as an allosteric modulator of CaR signalling. It has been shown in clinical studies to improve control of serum PTH levels and in preclinical studies to attenuate SHPT disease progression and parathyroid hyperplasia. Cinacalcet represents the first of this novel class of agents and a major advance in the treatment of SHPT.

[1]  E. Brown,et al.  The Ca2+‐Sensing Receptor (CaR) Activates Phospholipases C, A2, and D in Bovine Parathyroid and CaR‐Transfected, Human Embryonic Kidney (HEK293) Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  E. Slatopolsky,et al.  Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. , 2001, Kidney international.

[3]  J. Silver,et al.  The Effects of Calcium, Phosphate, and Vitamin D , 1995 .

[4]  J. Silver,et al.  Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. , 1986, The Journal of clinical investigation.

[5]  Wei Yang,et al.  Identification and Dissection of Ca2+-binding Sites in the Extracellular Domain of Ca2+-sensing Receptor* , 2007, Journal of Biological Chemistry.

[6]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[7]  J. Gogusev,et al.  Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. , 1997, Kidney international.

[8]  A. Scarpa,et al.  Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor. , 1987, The Journal of biological chemistry.

[9]  Yan Lu,et al.  1,25-Dihydroxyvitamin D downregulation of TGFα/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  N. Nagano.  Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. , 2006, Pharmacology & therapeutics.

[11]  R Pepperkok,et al.  Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts , 1993, The Journal of cell biology.

[12]  J. Silver,et al.  Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. , 1990, The Journal of clinical investigation.

[13]  J. Park,et al.  Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Spiegel,et al.  Identification of the Cysteine Residues in the Amino-terminal Extracellular Domain of the Human Ca2+ Receptor Critical for Dimerization , 1999, The Journal of Biological Chemistry.

[15]  J. Shiloach,et al.  Expression, Purification, and Biochemical Characterization of the Amino-terminal Extracellular Domain of the Human Calcium Receptor* , 1999, The Journal of Biological Chemistry.

[16]  E. Slatopolsky,et al.  Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. , 1999, Kidney international.

[17]  J. Silver,et al.  Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. , 1995, The Journal of clinical investigation.

[18]  D. Rognan,et al.  Delineating a Ca2+ Binding Pocket within the Venus Flytrap Module of the Human Calcium-sensing Receptor* , 2005, Journal of Biological Chemistry.

[19]  J. Silver,et al.  RNA-Protein Binding and Post-transcriptional Regulation of Parathyroid Hormone Gene Expression by Calcium and Phosphate* , 1998, The Journal of Biological Chemistry.

[20]  V. Torregrosa,et al.  The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis. , 2000, Journal of the American Society of Nephrology : JASN.

[21]  E. Nemeth,et al.  The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. , 2005, American journal of physiology. Renal physiology.

[22]  P. O'Hara,et al.  The Agonist-binding Domain of the Calcium-sensing Receptor Is Located at the Amino-terminal Domain* , 1999, The Journal of Biological Chemistry.

[23]  Fang Liu,et al.  Cyclin-dependent kinases regulate the antiproliferative function of Smads , 2004, Nature.

[24]  A. Dusso,et al.  p21WAF1 and transforming growth factor-α mediate dietary phosphate regulation of parathyroid cell growth , 2001 .

[25]  D. Lacey,et al.  Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl , 2004, Journal of Pharmacology and Experimental Therapeutics.

[26]  T. Sakaguchi,et al.  Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.

[27]  D. Lacey,et al.  Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. , 2005, Kidney international.

[28]  A. Dusso,et al.  p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. , 2001, Kidney international.

[29]  Kenneth A Jacobson,et al.  A Region in the Seven-transmembrane Domain of the Human Ca2+ Receptor Critical for Response to Ca2+* , 2005, Journal of Biological Chemistry.

[30]  E. Brown,et al.  Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. , 1996, The Journal of clinical endocrinology and metabolism.

[31]  M. Inaba,et al.  Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels , 2006, Journal of Bone and Mineral Metabolism.

[32]  E. Nemeth,et al.  Calcimimetic and calcilytic drugs: just for parathyroid cells? , 2004, Cell calcium.

[33]  A. Dusso,et al.  p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. , 2001, Kidney international.

[34]  A. Martín-Malo,et al.  Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans. , 2005, Journal of the American Society of Nephrology : JASN.

[35]  M. Hediger,et al.  Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid , 1993, Nature.

[36]  M F Balandrin,et al.  Calcimimetics with potent and selective activity on the parathyroid calcium receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[38]  A. Dusso,et al.  p21WAF1 and TGF-α mediate parathyroid growth arrest by vitamin D and high calcium , 2001 .

[39]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  D. Sherrard,et al.  A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. , 1998, Kidney international.

[41]  E. Ritz,et al.  1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. , 1989, Kidney international.

[42]  J. Silver,et al.  Regulation of the parathyroid hormone gene by calcium, phosphate and 1,25-dihydroxyvitamin D. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  J. T. Sullivan,et al.  No Effect of Renal Function or Dialysis on Pharmacokinetics of Cinacalcet (Sensipar®/Mimpara®) , 2005, Clinical pharmacokinetics.

[44]  E. Brown,et al.  Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. , 2001, American journal of physiology. Renal physiology.

[45]  Y. Tominaga.  Mechanism of parathyroid tumourigenesis in uraemia. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  E M Brown,et al.  Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs (*) , 1995, The Journal of Biological Chemistry.

[47]  A. Dusso,et al.  Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. , 1996, The Journal of clinical investigation.